Delivery Order SPE2DB20D1109-SPE2DB23FP36C

Award Date 6/20/23
Potential Completion Date 6/21/23
Potential Value $7.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $20,699.38 for the pharmaceutical product Trulicity 3 mg/0.5 ml pen 0.5 ml. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,168.87 for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,034.37 for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5ml. The contract was awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, and has an ultimate completion date of February 1, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $6,693.83 for the pharmaceutical product Trulicity 3 mg/0.5 ml pen. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,584.72 for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the Department of...
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,955.80 for the pharmaceutical product Trulicity 4.5 mg/0.5 ml pen. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 22, 2024. The contract is a firm fixed-price delivery order without any set-aside designations, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $6,629.56 for the pharmaceutical product Trulicity 3 mg/0.5 ml pen. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,604.88 for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $2,322.24 for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,560.60 for the pharmaceutical product Trulicity (0.75 mg/0.5 ml pen 0.5 ml). The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD), and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB23FP36C
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $7,243.66 for the pharmaceutical product Trulicity 1.5 mg/0.5 ml Pen. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This contract award is likely part of that larger IDC, enabling the DLA to efficiently procure essential medications like Trulicity to meet the healthcare needs of the Department of Defense (DoD) and Department of Veterans Affairs (VA).

Generated 2/27/25, 10:56 AM